HealthShare Victoria (HSV) wishes to inform suppliers of the upcoming release of a Request for Information (RFI) for the Opt-in State-wide Compounded Products tender.

HSV is exploring the market for the supply of compounded chemotherapy, monoclonal antibody (MAB) preparations and other sterile, compounded products and wishes to obtain additional information from suppliers regarding preferred contractual terms, pricing methods, and capability & logistics. Please note, additional information regarding contract scope will be included in the RFI documents upon release.

This RFI will be released via the HSV Procurement Portal on the 6th of February 2023 unless advised otherwise. Any changes to this release date will be provided via the HSV Website updates.

A formal market approach via an open tender will be released at a later stage.

Suppliers not submitting a response in the RFI will still be able to submit a response during the tender phase, however, we encourage all current and potential suppliers to complete this RFI.